APYX News and Press, Apyx Medical Corporation From 01/13/21

Gainers: [[DPW]] +46.3%. [[PFSW]] +39.9%. [[APYX]] +26.7%. [[MAXR]] +7.9%. [[SPCE]] +7.4%.Losers: [[SMLP]] -10.3%. [[VIRC]] -9.5%. [[VOLT]] -7.6%. [[TOUR]] -5.4%. [[HA]] -4.9%. For further details see: DPW, PFSW, APYX and VOLT among after-hours movers

Apyx Medical (APYX) shares shoot 26% after market as it reports Q4 preliminary total revenue in a range of ~$10.9-$11.3M, up ~30%-35% Y/Y.Q4 Advanced Energy revenue in a range of ~$9.5-$9.8M, up ~39%-43% Y/Y and OEM revenue ~$1.35-$1.45M, down ~5%-11% Y/Y. FY 2020: Total revenue in ...

Advanced Energy Sales of approximately $9.5 to $9.8 million in Q4, up 39% to 43% year-over-year Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and s...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announc...

InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...

Apyx Medical (APYX) has received FDA approval to begin Phase II of U.S. IDE clinical study evaluating the use of its Renuvion technology in skin laxity procedures in the neck and submental region. “The approved supplement included changes to the treatment protocol based on feedback fro...

Gainers: [[CANG]] +30.9%. [[DPW]] +14.3%. [[APYX]] +14.2%. [[ALT]] +11.4%. [[FCEL]] +9.1%.Losers: [[DAC]] -13.1%. [[RENN]] -10.8%. [[BLDP]] -7.3%. [[RGLD]] -7.1%. [[FF]] -5.9%. For further details see: DPW, CANG, DAC and RENN among after-hours movers

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

The following slide deck was published by Apyx Medical Corporation in conjunction with this event. For further details see: Apyx Medical (APYX) Investor Presentation - Slideshow

Apyx Medical Corporation (APYX) Q3 2020 Earnings Conference Call November 9, 2020 08:00 ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Matthew O’Brien - Pipe...